{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T04:07:37Z","timestamp":1772770057623,"version":"3.50.1"},"reference-count":31,"publisher":"Impact Journals, LLC","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,4,26]]},"DOI":"10.18632\/oncotarget.8286","type":"journal-article","created":{"date-parts":[[2016,3,23]],"date-time":"2016-03-23T10:34:56Z","timestamp":1458729296000},"page":"24228-24241","source":"Crossref","is-referenced-by-count":21,"title":["mTOR inhibition as an adjuvant therapy in a metastatic model of HPV+ HNSCC"],"prefix":"10.18632","volume":"7","author":[{"given":"Joseph D.","family":"Coppock","sequence":"first","affiliation":[{"name":"Cancer Biology Research Center, Sanford Research\/USD, Sioux Falls, SD 57104, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola D.","family":"Vermeer","sequence":"additional","affiliation":[{"name":"Cancer Biology Research Center, Sanford Research\/USD, Sioux Falls, SD 57104, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel W.","family":"Vermeer","sequence":"additional","affiliation":[{"name":"Cancer Biology Research Center, Sanford Research\/USD, Sioux Falls, SD 57104, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly M.","family":"Lee","sequence":"additional","affiliation":[{"name":"Cancer Biology Research Center, Sanford Research\/USD, Sioux Falls, SD 57104, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. Keith","family":"Miskimins","sequence":"additional","affiliation":[{"name":"Cancer Biology Research Center, Sanford Research\/USD, Sioux Falls, SD 57104, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C.","family":"Spanos","sequence":"additional","affiliation":[{"name":"Cancer Biology Research Center, Sanford Research\/USD, Sioux Falls, SD 57104, USA"},{"name":"Department of Otolaryngology\/Head and Neck Surgery, Sanford Health, Sioux Falls, SD 57105, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H.","family":"Lee","sequence":"additional","affiliation":[{"name":"Cancer Biology Research Center, Sanford Research\/USD, Sioux Falls, SD 57104, USA"},{"name":"Department of Otolaryngology\/Head and Neck Surgery, Sanford Health, Sioux Falls, SD 57105, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,3,23]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2982","article-title":"The molecular biology of head and neck cancer","volume":"11","author":"Brakenhoff","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"2","volume-title":"Cancer Facts & Figures 2013","author":"American Cancer Society","year":"2013"},{"key":"3","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1158\/0008-5472.CAN-10-3192","article-title":"Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer","volume":"71","author":"Gutkind","year":"2011","journal-title":"Cancer Res"},{"key":"4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11060-013-1075-9","article-title":"Metastatic squamous cell carcinoma to the brain: an unrecognized pattern of distant spread in patients with HPV-related head and neck cancer","volume":"112","author":"Westra","year":"2013","journal-title":"J Neurooncol"},{"key":"5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00000441-198606000-00007","article-title":"Management of advanced stage squamous cell carcinoma of the head and neck","volume":"291","author":"Forastiere","year":"1986","journal-title":"Am J Med Sci"},{"key":"6","first-page":"509036","article-title":"Impact of HPV in Oropharyngeal Cancer","volume":"2011","author":"Hammarstedt","year":"2011","journal-title":"J Oncol"},{"key":"7","first-page":"26","article-title":"HPV and head and neck cancer","volume":"129","author":"Lacau St Guily","year":"2011","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"8","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jama.2012.101","article-title":"Prevalence of Oral HPV Infection in the United States, 2009-2010","volume":"307","author":"Chaturvedi","year":"2012","journal-title":"J Am Med Assoc"},{"key":"9","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.otc.2012.04.004","article-title":"Clinical features of HPV-related head and neck squamous cell carcinoma: presentation and work-up","volume":"45","author":"Koch","year":"2012","journal-title":"Otolaryngol Clin North Am"},{"key":"10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archotol.133.5.495","article-title":"The role of human papilloma virus 16 E6 in anchorage independent and invasive growth of tonsil epithelium","volume":"133","author":"Lee","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"11","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archoto.2009.159","article-title":"Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer","volume":"135","author":"Lee","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"12","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1158\/0008-5472.CAN-06-2449","article-title":"Mammalian target of rapamycin inhibitors as possible adjuvant therapy for microscopic residual disease in head and neck squamous cell cancer","volume":"67","author":"Caldito","year":"2007","journal-title":"Cancer Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1593\/neo.13432","article-title":"Improved Clearance during Treatment of HPV-Positive Head and Neck Cancer through mTOR Inhibition","volume":"15","author":"Lee","year":"2013","journal-title":"Neoplasia"},{"key":"14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1593\/neo.131400","article-title":"Tumor Evolution and Intratumor Heterogeneity of an Oropharyngeal Squamous Cell Carcinoma Revealed by whole-genome sequencing","volume":"15","author":"M\u00e9ndez","year":"2013","journal-title":"Neoplasia"},{"key":"15","first-page":"409","article-title":"mTOR target NDRG1 confers MGMT-dependent resistance to alkylating chemotherapy","volume":"111","author":"Jugold","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"16","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1158\/1078-0432.CCR-11-2824","article-title":"mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous Carcinomas","volume":"18","author":"Gutkind","year":"2012","journal-title":"Clin Cancer Res"},{"key":"17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00109-013-1021-5","article-title":"The metastasis-promoting roles of tumor-associated immune cells","volume":"91","author":"Kang","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i1.10","article-title":"mTOR signaling in cancer cell motility and tumor metastasis","volume":"20","author":"Huang","year":"2010","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"19","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1517\/14728222.2011.541440","article-title":"EGFR-PI3K-AKT-mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy","volume":"15","author":"Van Waes","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"20","first-page":"450179","article-title":"Role of phosphatidylinositol-3-kinase pathway in head and neck squamous cell carcinoma","volume":"2012","author":"Lu","year":"2012","journal-title":"J Oncol"},{"key":"21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR Signaling in Growth Control and Disease","volume":"149","author":"Sabatini","year":"2012","journal-title":"Cell"},{"key":"22","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11864-011-0180-2","article-title":"mTOR inhibitors and its role in the treatment of head and neck squamous cell carcinoma","volume":"13","author":"Day","year":"2012","journal-title":"Curr Treat Options Oncol"},{"key":"23","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1758-3284-3-22","article-title":"Mammalian target of rapamycin and head and neck squamous cell carcinoma","volume":"3","author":"Yen","year":"2011","journal-title":"Head Neck Oncol"},{"key":"24","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1158\/1535-7163.MCT-08-1184","article-title":"Comparison of radiosensitizing effects of the mammalian target of rapamycin inhibitor CCI-779 to cisplatin in experimental models of head and neck squamous cell carcinoma","volume":"8","author":"Nathan","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"25","doi-asserted-by":"crossref","first-page":"4964","DOI":"10.1158\/1078-0432.CCR-07-1041","article-title":"Dissecting the Akt\/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative","volume":"13","author":"Gao","year":"2007","journal-title":"Clin Cancer Res"},{"key":"26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrc2817","article-title":"Targeting metabolic transformation for cancer therapy","volume":"10","author":"Gottlieb","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"27","first-page":"953089","article-title":"mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer","volume":"2012","author":"Wong","year":"2012","journal-title":"Otolaryngology"},{"key":"28","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1158\/2159-8290.CD-13-0239","article-title":"Exploiting the head and neck cancer oncogenome: widespread PI3K-mTOR pathway alterations and novel molecular targets","volume":"3","author":"Gutkind","year":"2013","journal-title":"Cancer Discov"},{"key":"29","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1038\/onc.2009.251","article-title":"Impaired PTPN13 phosphatase activity in spontaneous or HPV-induced squamous cell carcinomas potentiates oncogene signaling via the MAP kinase pathway","volume":"28","author":"Lee","year":"2009","journal-title":"Oncogene"},{"key":"30","first-page":"417","article-title":"Genotyping of 73 UM-SCC head and neck squamous cell carcinoma cell lines","volume":"32","author":"Carey","year":"2012","journal-title":"Head Neck"},{"key":"31","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1158\/1940-6207.CAPR-08-0147","article-title":"Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model","volume":"2","author":"Gutkind","year":"2009","journal-title":"Cancer Prev Res (Phila)"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8286","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T20:10:19Z","timestamp":1589227819000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.8286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,23]]},"references-count":31,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2016,4,26]]}},"alternative-id":["8286","27015118"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.8286","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,23]]}}}